BIOMAT Database Logo BIOMAT Database Logo

Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70. 1971

R Gold, and M S Artenstein

A second large-scale field trial of group C meningococcal polysaccharide vaccine in US Army recruits confirmed the efficacy and safety of the vaccine. When the results of all studies over a 2-year period were combined, the reduction in group-specific disease rates was 89.5%.

UI MeSH Term Description Entries
D008297 Male Males
D008589 Meningococcal Infections Infections with bacteria of the species NEISSERIA MENINGITIDIS. Meningococcal Septicemia,Infections, Meningococcal,Meningococcal Disease,Infection, Meningococcal,Meningococcal Diseases,Meningococcal Infection,Septicemia, Meningococcal
D008887 Military Medicine The practice of medicine as applied to special circumstances associated with military operations. Medicine, Military
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

R Gold, and M S Artenstein
Vaccine potential of meningococcal group C polysaccharide-tetanus toxoid conjugate.
May 1983, The Journal of infection,
R Gold, and M S Artenstein
[Efficacy of the meningococcal vaccine from Group C capsular polysaccharide].
January 1997, Revista espanola de salud publica,
R Gold, and M S Artenstein
A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.
March 1995, The Journal of infectious diseases,
R Gold, and M S Artenstein
[Meningococcal C polysaccharide vaccine in Andalucia].
December 2000, Anales espanoles de pediatria,
R Gold, and M S Artenstein
Meningococcal infections. 4. Stability of group A and group C polysaccharide vaccines.
January 1971, Bulletin of the World Health Organization,
R Gold, and M S Artenstein
A controlled field trial of a serogroup A meningococcal polysaccharide vaccine.
June 1973, Bulletin of the World Health Organization,
R Gold, and M S Artenstein
Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial.
June 2000, Vaccine,
R Gold, and M S Artenstein
[Reactogenicity of a group A and C meningococcal polysaccharide bivalent vaccine].
July 1986, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
R Gold, and M S Artenstein
[Immunogenicity of group A+C meningococcal polysaccharide conjugate vaccine in infants: A phase Ⅲ clinical trial study].
December 2022, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
R Gold, and M S Artenstein
[Evaluation on the safety of a group A + C meningococcal polysaccharide vaccine].
May 2007, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
Copied contents to your clipboard!